Concord Medical Services Holdings Limited, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company is headquartered in Beijing, the People's Republic of China.
| Revenue (TTM) | $460.51M |
| Gross Profit (TTM) | $25.82M |
| EBITDA | $-99.70M |
| Operating Margin | -36.40% |
| Return on Equity | -21.90% |
| Return on Assets | -2.25% |
| Revenue/Share (TTM) | $105.42 |
| Book Value | $-70.93 |
| Price-to-Book | 3.02 |
| Price-to-Sales (TTM) | 0.05 |
| EV/Revenue | 7.5 |
| EV/EBITDA | -0.96 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 57.40% |
| Shares Outstanding | $2.82M |
| Float | $41.94M |
| % Insiders | 18.00% |
| % Institutions | 0.04% |
Volatility is currently expanding